Bookmark

Add to MyYahoo RSS

Leukeran, Chlorambucil News

News on Leukeran, Chlorambucil (generic) continually updated from thousands of sources around the net.

Tuesday Jul 29 | BioSpace

Roche??'s Gazyvaro Approved In Europe For Patients With The Most Common Type Of Leukemia

Gazyvaro, the first type II, glycoengineered anti-CD20 monoclonal antibody is now approved in Europe for patients with previously untreated chronic lymphocytic leukemia Approval is based on the phase III CLL11 study which showed that Gazyvaro plus chlorambucil chemotherapy significantly extended the amount of time people lived without their disease ... (more)

Comment?

Related Topix: Leukemia, Health, Medicine

Sun Jul 13, 2014

CiteULike

Metronomic administration of chlorambucil for treatment of dogs with...

To determine the antitumor effects and toxicoses of metronomic oral administration of a low dose of chlorambucil in dogs with transitional cell carcinoma .

Comment?

Related Topix: Medicine

Thu Jul 03, 2014

GlobeNewswire

GSK and Genmab Receive EU Authorization for Arzerra (ofatumumab) as...

Arzerra approved for use in EU as first-line treatment for CLL in combination with chlorambucil or bendamustine for patients ineligible for fludarabine-based therapy Approval based on Phase III data from study with ofatumumab + chlorambucil & Phase II data from study with ofatumumab and bendamustine GlaxoSmithKline plc and Genmab A/S announced ... (more)

Comment?

Related Topix: Biotech, GlaxoSmithKline, Healthcare Industry, Leukemia, Health, Oncology

Wed Jun 18, 2014

BioSpace

Roche Medicine Gazyvaro Granted Approval For The Therapy Of Patients...

Roche Medicine Gazyvaro Granted Approval For The Therapy Of Patients With Previously Untreated Chronic Lymphocytic Leukemia And Co-Existing Medical Conditions In Switzerland In a head-to-head comparison with standard therapy with MabThera, Gazyvaro in combination with chemotherapy reduces the risk of disease progression or death in CLL patients by ... (more)

Comment?

Related Topix: Leukemia, Health, Medicine, Marketing, Hematology

•••
•••
•••
•••
•••
•••
•••